Exelixis Clinical Site #1 — Indianapolis, Indiana

Exelixis Clinical Site #1 is a clinical research site located in Indianapolis, Indiana, United States 46250.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #1 has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).

Sponsors: Exelixis.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #1?

Exelixis Clinical Site #1 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #1 conducted?

Exelixis Clinical Site #1 has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).

Is Exelixis Clinical Site #1 accredited by Crixeo Health?

Exelixis Clinical Site #1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.